Two manufacturing businesses, one in Europe, one in the United States, sit almost side by side on paper. Similar footprint, similar stock levels, similar leased premises, and cash flow that lines up within a rounding error. Both go to market at the same time.
The bids that come back tell a different story. The two businesses are worth noticeably different amounts, despite running on the same underlying economics.
No one in either process made a mistake. The gap opens up because the two companies are required to report their financial results under different accounting frameworks, and that alone is enough to shift reported earnings, the multiple applied, and the eventual price. For anyone working across borders on a deal, that gap is not academic. It shows up directly in the number that changes hands.
Cash Doesn’t Care About Accounting Rules. Buyers Do.
Strip everything back and a business is worth what it can generate in future cash, and cash itself does not know or care whether an asset was written off over five years or ten. On that basis, it is tempting to treat accounting frameworks as background noise that a good valuation should simply see through.
That assumption falls apart the moment a deal actually gets priced.
The metrics every valuation leans on, EBITDA, EBIT, net profit, gearing, the tax line, are all products of accounting policy, not neutral facts sitting outside it. Once a transaction crosses borders, putting both sides’ financials on a common footing stops being a nice extra and becomes a basic requirement of doing the analysis properly.
Four Places Where GAAP and IFRS Pull the Numbers Apart
How revenue lands on the page. IFRS 15 and its US counterpart, ASC 606, share the same broad five-step framework, but the detail of how each is applied diverges, especially on long-term contracts, licensing deals, and consideration that varies. Any shift in timing matters most in the earliest years of a discounted cash flow, since those years carry the heaviest weighting in the final number. A small revenue-timing quirk near the front of a forecast can move the valuation more than most people expect.
Where leases sit on the balance sheet. This is the area that causes the most trouble in practice. IFRS 16 pulls almost every lease onto the balance sheet as a right-of-use asset with a matching liability, strips the lease cost out of the income statement, and replaces it with depreciation and interest. The net effect: EBITDA climbs, depreciation climbs, and reported debt climbs with it. US GAAP, under ASC 842, keeps the older split between operating and finance leases, so operating lease costs still sit inside operating expenses and EBITDA stays comparatively lower. Line up an IFRS business against a US GAAP comparable on a raw EV/EBITDA multiple and the two numbers are simply not measuring the same thing, particularly where the business leans heavily on leased space or equipment.
How inventory is costed. US GAAP still permits Last-In, First-Out costing. IFRS has ruled it out entirely. When costs are climbing, LIFO pushes reported inventory values down, trims taxable income, and reduces the cash tax bill, and that is a genuine economic outcome, not a quirk of presentation. Comparing a LIFO-based US business with an international peer without unwinding the LIFO reserve means comparing two different pictures of the same kind of business.
The smaller items that still add up. IFRS allows development costs to be capitalized once a project clears the technical feasibility bar, while US GAAP expenses nearly all R&D as it is spent, which tends to leave IFRS balance sheets carrying more assets and smoother-looking earnings. Impairment rules differ too, in how testing units are defined and whether a past writedown can later be reversed, both of which touch book equity and credit metrics. Deferred tax and currency translation can also generate earnings swings that look dramatic without reflecting much real economic change underneath.
Why This Matters Differently Depending on Where You Sit
For law firms, investment banks, and advisory teams, the danger is building a set of comparables that are quietly contaminated. Line up an IFRS target against US GAAP-reporting peers without adjusting for leases, stock, and revenue timing, and the resulting multiple is compromised before it even reaches the negotiating table, leaving the analysis exposed under pressure. The teams that hold up best are the ones building normalization schedules as routine practice, stripping out the IFRS 16 effect, correcting for LIFO reserves, and restating revenue timing before any market-based method gets applied.
For privately owned businesses, a cross-border sale might feel like a remote possibility, but plenty of buyers and lenders now operate under a different accounting standard than the target’s own management accounts. Owners heading toward an exit are better served by understanding, ahead of time, how their numbers would read to a buyer working from the other framework. That means lease commitments that are properly visible and correctly classified, an inventory approach that is clearly documented, and paper trails behind any capitalized development spend. Buyers who run into unfamiliar treatment mid-diligence often respond by knocking a discount off the price for the uncertainty. Sellers who get ahead of that conversation tend to keep more of the narrative in their own hands, and more of the proceeds in their own pocket.
The Short Version
A cross-border valuation is, at its core, an exercise in translation. Part of that job is separating the differences that are purely cosmetic from the ones that carry real economic weight, adjusting for the latter and leaving the former well alone.
Two businesses generating the same cash can present two very different sets of financial statements, purely because of how they treat leases, stock, or development spend. Understanding why that gap exists is step one. Correcting for it, and being ready to defend that correction under deal-room scrutiny, is the work that actually protects the value on the table.